AHA/ASA发布女性卒中预防指南

2014-02-08 AHA/ASA相关专家组 医学论坛网

美国心脏学会联合美国卒中学会(AHA/ASA)发布了《女性卒中预防指南》,指南针对子痫前期患者阿司匹林的使用、避孕药的应用或绝经后激素替代者的卒中预防等女性特殊情况做出了建议,全文2月6日在线发表于《卒中》(Stroke)杂志。 指南下载:Guidelines for the Prevention of Stroke in Women A Statement for Healthc

美国心脏学会联合美国卒中学会(AHA/ASA)发布了《女性卒中预防指南》,指南针对子痫前期患者阿司匹林的使用、避孕药的应用或绝经后激素替代者的卒中预防等女性特殊情况做出了建议,全文2月6日在线发表于《卒中》(Stroke)杂志。

尽管卒中在男性和女性身上都很常见,美国心脏学会和美国卒中学会指南首度指出,妊娠、服避孕药和停经等因素使得女性卒中风险高于男性。

美国心脏学会(American Heart Association)和美国卒中学会(American Stroke Association)公布最新指南,希望协助医师和患者提早了解卒中风险因素,以及早预防。

美国心脏学会期刊《卒中》(Stroke)最新科学声明主笔布什奈尔(Cheryl Bushnell)说:“女性有许多卒中风险因素和男性一样,但也会受激素、生育健康、妊娠、分娩和其他与性别有关的因素影响。”

根据报告,美国平均每年约有80万卒中病例,女性占一半以上,卒中致死案例有6成是女性。卒中是男性第5大死因,女性则是第3大。

男女共同卒中风险因子包括高血压、高胆固醇、吸烟、糖尿病等。最新指导方针说,女性特别容易卒中的因素,还包括常见的妊娠并发症、服避孕药、激素补充疗法、偏头痛和心脏问题。

指导方针同时就如何筛检女性卒中风险因素及预防提供家庭医师和妇产科医师建议,包括严格评估任何曾经历妊娠毒血症的女性,因为怀孕期间血压升高的危险状况,可能会让女性卒中风险倍增。

对于怀孕期间曾有高血压的妇女,医师应考虑降低阿司匹林或其他必要药物的剂量。至于到生育年龄的女性,应该在给她们避孕药前筛检高血压,并应提醒她们不要吸烟。

此外,较年长女性应检查是否有心律不整,因为这可能会使75岁以上女性卒中风险提高5倍。


指南下载:

Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858425, encodeId=0a8e18584252b, content=<a href='/topic/show?id=efd52810cc' target=_blank style='color:#2F92EE;'>#ASA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2810, encryptionId=efd52810cc, topicName=ASA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Fri Feb 14 17:49:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267202, encodeId=0f3c126e20261, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447374, encodeId=e5d8144e37451, content=<a href='/topic/show?id=35cc36081e2' target=_blank style='color:#2F92EE;'>#卒中预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36081, encryptionId=35cc36081e2, topicName=卒中预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd925339785, createdName=陈吴1236, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=)]
    2014-02-14 lvygwyt2781
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858425, encodeId=0a8e18584252b, content=<a href='/topic/show?id=efd52810cc' target=_blank style='color:#2F92EE;'>#ASA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2810, encryptionId=efd52810cc, topicName=ASA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Fri Feb 14 17:49:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267202, encodeId=0f3c126e20261, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447374, encodeId=e5d8144e37451, content=<a href='/topic/show?id=35cc36081e2' target=_blank style='color:#2F92EE;'>#卒中预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36081, encryptionId=35cc36081e2, topicName=卒中预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd925339785, createdName=陈吴1236, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=)]
    2014-02-10 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858425, encodeId=0a8e18584252b, content=<a href='/topic/show?id=efd52810cc' target=_blank style='color:#2F92EE;'>#ASA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2810, encryptionId=efd52810cc, topicName=ASA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Fri Feb 14 17:49:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267202, encodeId=0f3c126e20261, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447374, encodeId=e5d8144e37451, content=<a href='/topic/show?id=35cc36081e2' target=_blank style='color:#2F92EE;'>#卒中预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36081, encryptionId=35cc36081e2, topicName=卒中预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd925339785, createdName=陈吴1236, createdTime=Mon Feb 10 01:49:00 CST 2014, time=2014-02-10, status=1, ipAttribution=)]